New Leads in Slowing Parkinson's
WebMD - Feb 24, 2006 24, 2006 -- A new study shows that two compounds -- creatine and minocycline -- might deserve more research to see if they slow down Parkinson's disease. ...
|
|
|
|
Drugs for brain growth.(Brief article)
Free with registration - Technology Review - AccessMyLibrary.com - Sep 1, 2006 Company Primary target Approach NeuroNova Parkinson's disease Screening compounds for their Stockholm, Sweden ability to boost growth of new neurons ...
|
|
|
|
Evotec AG
$1,480.00 - LIFE SCIENCE ANALYTICS - Alacra Store - May 23, 2006 neuropathic pain and Parkinson's disease. Its discovery and development platform is ... licensing agreement with Roche for two compounds in phase I clinical ...
|
|
Evotec AG
$1,480.00 - LIFE SCIENCE ANALYTICS - Alacra Store - May 22, 2006 neuropathic pain and Parkinson's disease. Its discovery and development platform is ... licensing agreement with Roche for two compounds in phase I clinical ...
|
|
Evotec AG
$1,440.00 - LIFE SCIENCE ANALYTICS - Alacra Store - Apr 15, 2006 neuropathic pain and Parkinson's disease. Its discovery and development platform is ... licensing agreement with Roche for two compounds in phase I clinical ...
|
|
Evotec AG
$1,440.00 - LIFE SCIENCE ANALYTICS - Alacra Store - Mar 19, 2006 neuropathic pain and Parkinson's disease. Its discovery and development platform is ... licensing agreement with Roche for two compounds in phase I clinical ...
|
|